NOVATEK PHARMACEUTICALS

WHO WE ARE

Unmet Medical Need

Who we are

Novatek Pharmaceuticals Inc., was recently formed based on years of experience with thymoquinone in oncology patients combined with recent publications suggesting that thymoquinone may also have potential in many other indications including Sars-CoV2. The company will closely manage work sub-contracted to CROs and CDMOs. We have a team of clinically trained professionals with extensive experience in pharmacology, oncology, and clinical research.

We are a company that focuses on the potentially beneficial roles of TQ against COVID-19 pathophysiology in the context of antioxidant, anti-inflammatory, immunomodulatory, epigenetic modulation, antiviral activity, docking studies on anti-COVID-19 activity, antibacterial and anticoagulant effects for the treatment of COVID-19.

What is a black seed? The Black Seed is scientifically known as Nigella Sativa. The plant grows about 40-60cm in height, and from it comes many small rectangular Black Seed, quite commonly known as ‘The Blessed Seed’. As well as being a fantastic culinary herb in its own right, it also has many medicinal uses due to its antiviral, anti-inflammatory, anti-fungal, antioxidant, antibacterial, anti-asthmatic, anticoagulant and anti-histimic properties.

Many people know of the Black Seed and have even eaten it before, yet just do not realise. For example Naan breads (particularly here in the UK with our love for Indian food), more often than not are come garnished with Nigella Sativa seeds. The same goes for flatbreads. They are what gives the bread that delicious herby & earthy taste and aroma. There are many other culinary uses for the Black Seed such as including them in soups, smoothies, rice dishes, curries and spice mixes

CHIEF EXECUTIVE OFFICER

With over 22 years of experience in the pharmaceutical industry, Mr. Kaseb brings a wide range of values in the areas of patient services, commercial strategies, sales, marketing and pharmacy operations. As Chief Executive Officer, Mr. Kasseb uses strategy and innovation to drive business.

Mr. Kaseb has worked numerous roles throughout his 22 years of professional pharmaceutical career, including: serving as a team member of an international pharmaceutical company developing and expanding their business development strategy, as well as in-patient clinical hospital experience at Oakwood hospital in the State of Michigan, as well as holding multiple managerial positions at both CVS Health and Walgreens for over a decade.

Mr. Kaseb is a registered pharmacist and holds a B.Sc. degree from Cairo University, Egypt and became a registered pharmacist in 1997.  He passed his Foreign Pharmacy Graduate Equivalency Exam in 2000 and became a registered pharmacist in State of Michigan, and later a registered pharmacist and a resident in the State of Texas in 2009.

Mr. Kaseb is passionate about leading, coaching, mentoring, and developing successful teams. He is an accomplished entrepreneur and is currently the President and Co-founder of the Kaseb Foundation and is actively involved in and supportive of multiple charities, specifically those that help needy children, orphans and fighting poverty.

Mohamed Kaseb, RPh

Mohamed Kaseb, RPh

CHIEF EXECUTIVE OFFICER

With over 22 years of experience in the pharmaceutical industry, Mr. Kaseb brings a wide range of values in the areas of patient services, commercial strategies, sales, marketing and pharmacy operations. As Chief Executive Officer, Mr. Kasseb uses strategy and innovation to drive business.

Mr. Kaseb has worked numerous roles throughout his 22 years of professional pharmaceutical career, including: serving as a team member of an international pharmaceutical company developing and expanding their business development strategy, as well as in-patient clinical hospital experience at Oakwood hospital in the State of Michigan, as well as holding multiple managerial positions at both CVS Health and Walgreens for over a decade.

Mr. Kaseb is a registered pharmacist and holds a B.Sc. degree from Cairo University, Egypt and became a registered pharmacist in 1997.  He passed his Foreign Pharmacy Graduate Equivalency Exam in 2000 and became a registered pharmacist in State of Michigan, and later a registered pharmacist and a resident in the State of Texas in 2009.

Mr. Kaseb is passionate about leading, coaching, mentoring, and developing successful teams. He is an accomplished entrepreneur and is currently the President and Co-founder of the Kaseb Foundation and is actively involved in and supportive of multiple charities, specifically those that help needy children, orphans and fighting poverty.

CHIEF OPERATING OFFICER

As Chief Operation Officer, Mr. Osama Kasseb is responsible for translating Novatek Pharmaceutical’s vision into achievable goals by leading the execution of short- and long-term growth strategies to meet company goals. He inspires engagement, participation and commitment from various stakeholders in order to accomplish meaningful goals.

Mr. Osama Kasseb received his Bachelor of Pharmacy from Misr International University, in Cairo, Egypt in 2007.  Completing his Foreign Pharmacy Graduate Equivalency Committee Certification in 2008, and became a licensed and registered pharmacist in both Texas and Michigan in 2009 and quickly identified his love for independent community pharmacy. 

Mr. Kasseb has completed multiple educational trainings to expand his knowledge and expertise in various pharmacy sectors including the Professional Compounding Centers of America (PCCA)’s Educational Training to specialize in compounding and hormonal replacement therapies in 2012.

Mr. Kasseb has served in many leadership capacities, including President of Pharmacy Management Services in Houston, where he established business coaching to over 8 independent pharmacies. Under Mr. Kasseb’s leadership and coaching, his pharmacies saw solid topline growth and expanded their services to help more patients access prescription medications. Mr. Kasseb is proud to hold multiple accreditations in his facilities including Accreditation Commission for Health Care (ACHC) that administers the Pharmacy Compounding Accreditation Board (PCAB) and Healthcare Quality Association on Accreditation (HQAA). Osama is a Co-founder of the Kaseb Foundation and is actively involved in and supportive of multiple charities, specifically those that help needy children, orphans and fighting poverty. Mr. Kasseb lives in Pearland, TX with his wife Dalia Kasseb, who is a clinical pharmacist, and their sons Hussein & Taha.

Osama Kasseb, RPh

Osama Kasseb, RPh

CHIEF OPERATING OFFICER

As Chief Operation Officer, Mr. Osama Kasseb is responsible for translating Novatek Pharmaceutical’s vision into achievable goals by leading the execution of short- and long-term growth strategies to meet company goals. He inspires engagement, participation and commitment from various stakeholders in order to accomplish meaningful goals.

Mr. Osama Kasseb received his Bachelor of Pharmacy from Misr International University, in Cairo, Egypt in 2007.  Completing his Foreign Pharmacy Graduate Equivalency Committee Certification in 2008, and became a licensed and registered pharmacist in both Texas and Michigan in 2009 and quickly identified his love for independent community pharmacy. 

Mr. Kasseb has completed multiple educational trainings to expand his knowledge and expertise in various pharmacy sectors including the Professional Compounding Centers of America (PCCA)’s Educational Training to specialize in compounding and hormonal replacement therapies in 2012.

Mr. Kasseb has served in many leadership capacities, including President of Pharmacy Management Services in Houston, where he established business coaching to over 8 independent pharmacies. Under Mr. Kasseb’s leadership and coaching, his pharmacies saw solid topline growth and expanded their services to help more patients access prescription medications. Mr. Kasseb is proud to hold multiple accreditations in his facilities including Accreditation Commission for Health Care (ACHC) that administers the Pharmacy Compounding Accreditation Board (PCAB) and Healthcare Quality Association on Accreditation (HQAA). Osama is a Co-founder of the Kaseb Foundation and is actively involved in and supportive of multiple charities, specifically those that help needy children, orphans and fighting poverty. Mr. Kasseb lives in Pearland, TX with his wife Dalia Kasseb, who is a clinical pharmacist, and their sons Hussein & Taha.

Chief Clinical Officer

Karim is the founder and CEO of Tranquil Clinical Research and has over 20 years of clinical trial experience. Karim’s dedication to quality and patient care started when he was only 18 years old and was Medic-In-Charge of a 911 EMS unit in the suburbs of Houston. While Karim pursued his degree during the day, he worked full time at night for a level one hospital in Houston as lead emergency trauma technician.

After receiving his BA Biology and Minor in Philosophy at the University of St. Thomas, Karim attended an intensive medical internship at Case Western Reserve University and then went on to launch his research career at the University of Texas Health Science Center Houston (UTHSC). While working at UT, with the department of Internal Medicine, Karim wrote Investigator Initiated protocols, abstracts and worked as a clinical research coordinator.  From there Karim was recruited into the CRO industry and Over the past 20 years Karim has served as a study coordinator, clinical operations specialist, CRA, Lead CRA, clinical trial manager, project lead, project manager and ultimately in his current role as CEO for TCR. His dedication to training and developing an effective team of clinical researchers has allowed him to lead Tranquil Clinical Research to become a successful and growing organization committed to quality clinical trial development and efficient trial conduct.

Karim Mohammed

Chief Legal Officer

Peter Tu is the Founding Partner of the Law Offices of Peter Tu, where his practice focuses on intellectual property law (patents, copyrights, trademarks and trade secrets), licensing and other transactional matters, and dispute resolution (litigation, arbitration and mediation). While Mr. Tu has represented clients both large and small, his in-house experience at various life sciences start-ups and his innovative alternative fee arrangements (such as the GC On Call and IP Counsel On Call programs) have been of greatest benefit to start-ups and emerging growth companies without in-house legal counsel.

Prior to forming his law firm, Mr. Tu spent twenty years as in-house counsel in the pharmaceutical and biotechnology industries. His last in-house position was as General Counsel and Chief Legal Officer for Signum Biosciences, a private biotechnology company focusing on the development of novel, small-molecule therapeutics to modulate signal transduction imbalances; in that capacity, Mr. Tu headed up the legal function for Signum and its subsidiaries, and was a member of Signum’s executive management team.

In 2002, Mr. Tu was selected by the National Asian Pacific American Bar Association as one of the Best Lawyers Under 40 in the United States. Only twenty-five attorneys throughout the country were selected to receive this prestigious designation and award.

Peter Tu

Peter Tu

Chief Legal Officer

Peter Tu is the Founding Partner of the Law Offices of Peter Tu, where his practice focuses on intellectual property law (patents, copyrights, trademarks and trade secrets), licensing and other transactional matters, and dispute resolution (litigation, arbitration and mediation). While Mr. Tu has represented clients both large and small, his in-house experience at various life sciences start-ups and his innovative alternative fee arrangements (such as the GC On Call and IP Counsel On Call programs) have been of greatest benefit to start-ups and emerging growth companies without in-house legal counsel.

Prior to forming his law firm, Mr. Tu spent twenty years as in-house counsel in the pharmaceutical and biotechnology industries. His last in-house position was as General Counsel and Chief Legal Officer for Signum Biosciences, a private biotechnology company focusing on the development of novel, small-molecule therapeutics to modulate signal transduction imbalances; in that capacity, Mr. Tu headed up the legal function for Signum and its subsidiaries, and was a member of Signum’s executive management team.

In 2002, Mr. Tu was selected by the National Asian Pacific American Bar Association as one of the Best Lawyers Under 40 in the United States. Only twenty-five attorneys throughout the country were selected to receive this prestigious designation and award.

Karim Mohammed

Chief Clinical Officer

Karim is the founder and CEO of Tranquil Clinical Research and has over 20 years of clinical trial experience. Karim’s dedication to quality and patient care started when he was only 18 years old and was Medic-In-Charge of a 911 EMS unit in the suburbs of Houston. While Karim pursued his degree during the day, he worked full time at night for a level one hospital in Houston as lead emergency trauma technician.

After receiving his BA Biology and Minor in Philosophy at the University of St. Thomas, Karim attended an intensive medical internship at Case Western Reserve University and then went on to launch his research career at the University of Texas Health Science Center Houston (UTHSC). While working at UT, with the department of Internal Medicine, Karim wrote Investigator Initiated protocols, abstracts and worked as a clinical research coordinator.  From there Karim was recruited into the CRO industry and Over the past 20 years Karim has served as a study coordinator, clinical operations specialist, CRA, Lead CRA, clinical trial manager, project lead, project manager and ultimately in his current role as CEO for TCR. His dedication to training and developing an effective team of clinical researchers has allowed him to lead Tranquil Clinical Research to become a successful and growing organization committed to quality clinical trial development and efficient trial conduct.

 

NOVATEK PHARMACEUTICALS

Live Healthier

Please contact us